Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Borzillo V, Scipilliti E, Pezzulla D, Serra M, Ametrano G, Quarto G, Perdonà S, Rossetti S, Pignata S, Crispo A, Di Gennaro P, D'Alesio V, Arrichiello C, Buonanno F, Mercogliano S, Russo A, Tufano A, Di Franco R, Muto P.
Borzillo V, et al. Among authors: perdona s.
Front Oncol. 2023 Nov 7;13:1270498. doi: 10.3389/fonc.2023.1270498. eCollection 2023.
Front Oncol. 2023.
PMID: 38023175
Free PMC article.